Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual antiplatelet therapy versus aspirin alone after CABG
IRCT20171113037434N1Phase 2Completed
- Sponsor
- Sanofi
- Start
- May 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of clopidogrel and aspirin in coronary arteriosclerosis (2 arms), sponsored by Sanofi. Started May 2012; status: completed.
02
Drugs
clopidogrelaspirin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20171113037434N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171113037434N1.